TherapeuticsMD Inc. buy stratec
Start price
26.10.18
/
50%
€242.64
Target price
04.11.21
€200.00
Performance (%)
-86.61%
End price
05.11.21
€32.50
Summary
This prediction ended on 05.11.21 with a price of €32.50. The BUY prediction by stratec for TherapeuticsMD Inc. performed very badly with a performance of -86.61%. stratec has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| TherapeuticsMD Inc. | -1.149% | -1.149% | 84.946% | -53.514% |
| iShares Core DAX® | 2,57 % | 3,50 % | 8,41 % | 62,27 % |
| iShares Nasdaq 100 | 4,86 % | 0,65 % | 28,38 % | 85,45 % |
| iShares Nikkei 225® | 5,59 % | -0,25 % | 52,92 % | 76,58 % |
| iShares S&P 500 | 3,25 % | 2,08 % | 24,37 % | 68,71 % |
Comments by stratec for this prediction
In the thread Therapeuticsmd Inc. diskutieren
stratec stimmt der Buy-Einschätzung der institutionellen Analysten zu
TherapeuticsMD announces that it is discussing labeling with the FDA related to hormone therapy candidate TX-001HR.
The agency's action date for its proposed use for treating moderate-to-severe vasomotor symptoms due to menopause is October 28, but a decision may be announced today.
Kursziel geändert auf 4,0
In the thread Trading Therapeuticsmd Inc.
Die von stratec gewählte maximale Laufzeit wurde überschritten